Home
About
Services
Partners
Client Portfolio
News
Contact
HSBC HK shareholders mull legal action over dividend suspension
April 6, 2020
Uber connects out-of-work U.S. ride-hail drivers to delivery, production jobs
April 6, 2020
0
GSK to partner with Vir for potential COVID-19 treatments, invest $250 million
Published by
Muller&Green
at
April 6, 2020
Categories
RSS
Tags
British drugmaker GlaxoSmithKline will invest $250 million in Vir Biotechnology Inc and collaborate to develop potential treatments for COVID-19, the disease caused by the new coronavirus, the companies said on Monday.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more